L-glutamamide L-peptide linking ATOMP C5 H11 N3 O2 0 2016-03-21 2016-04-01 N REL 145.160 6E4 N Corina N 5IVN EBI N1 N 0 1 N N N -10.546 -17.590 17.343 3.819 -0.268 0.277 N01 6E4 1 C1 C 0 1 N N N -11.434 -17.758 16.309 2.596 0.193 -0.055 C02 6E4 2 O1 O 0 1 N N N -11.123 -18.409 15.310 2.488 1.172 -0.762 O03 6E4 3 C2 C 0 1 N N N -12.757 -17.101 16.415 1.363 -0.510 0.454 C04 6E4 4 C3 C 0 1 N N N -13.817 -18.121 16.507 0.116 0.210 -0.064 C05 6E4 5 C4 C 0 1 N N S -15.157 -17.516 16.326 -1.135 -0.503 0.452 C06 6E4 6 N2 N 0 1 N N N -15.485 -16.647 17.425 -1.200 -1.855 -0.120 N07 6E4 7 C5 C 0 1 N N N -16.152 -18.656 16.273 -2.360 0.274 0.044 C08 6E4 8 N3 N 0 1 N N N -16.738 -19.038 17.436 -2.732 1.363 0.746 N09 6E4 9 O2 O 0 1 N N N -16.487 -19.214 15.199 -3.012 -0.080 -0.915 O10 6E4 10 H1 H 0 1 N N N -9.635 -17.998 17.291 3.905 -1.051 0.842 H1 6E4 11 H2 H 0 1 N N N -10.811 -17.059 18.148 4.612 0.182 -0.054 H2 6E4 12 H3 H 0 1 N N N -12.780 -16.469 17.315 1.361 -1.541 0.101 H3 6E4 13 H4 H 0 1 N N N -12.927 -16.477 15.525 1.362 -0.498 1.544 H4 6E4 14 H5 H 0 1 N N N -13.770 -18.600 17.496 0.119 1.241 0.288 H5 6E4 15 H6 H 0 1 N N N -13.656 -18.878 15.725 0.117 0.199 -1.154 H6 6E4 16 H7 H 0 1 N N N -15.189 -16.961 15.377 -1.093 -0.570 1.539 H7 6E4 17 H8 H 0 1 N N N -14.829 -15.893 17.462 -1.240 -1.819 -1.128 H8 6E4 18 H9 H 0 1 N N N -16.407 -16.281 17.297 -0.422 -2.417 0.191 H9 6E4 19 H11 H 0 1 N N N -17.431 -19.759 17.433 -2.211 1.646 1.514 H11 6E4 20 H12 H 0 1 N N N -16.477 -18.599 18.295 -3.520 1.863 0.484 H12 6E4 21 doub N N 1 doub N N 2 sing N N 3 sing N N 4 sing N N 5 sing N N 6 sing N N 7 sing N N 8 sing N N 9 sing N N 10 sing N N 11 sing N N 12 sing N N 13 sing N N 14 sing N N 15 sing N N 16 sing N N 17 sing N N 18 sing N N 19 sing N N 20 NC(CCC(N)C(N)=O)=O InChI=1S/C5H11N3O2/c6-3(5(8)10)1-2-4(7)9/h3H,1-2,6H2,(H2,7,9)(H2,8,10)/t3-/m0/s1 LCGISIDBXHGCDW-VKHMYHEASA-N N[C@@H](CCC(N)=O)C(N)=O N[CH](CCC(N)=O)C(N)=O C(CC(=O)N)[C@@H](C(=O)N)N C(CC(=O)N)C(C(=O)N)N L-glutamamide (2~{S})-2-azanylpentanediamide EBI RCSB